These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26003847)

  • 21. Hepatic mitochondrial DNA/Toll-like receptor 9/MicroRNA-223 forms a negative feedback loop to limit neutrophil overactivation and acetaminophen hepatotoxicity in mice.
    He Y; Feng D; Li M; Gao Y; Ramirez T; Cao H; Kim SJ; Yang Y; Cai Y; Ju C; Wang H; Li J; Gao B
    Hepatology; 2017 Jul; 66(1):220-234. PubMed ID: 28295449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulated expression of microRNA-124 in pediatric intestinal failure patients modulates macrophages activation by inhibiting STAT3 and AChE.
    Xiao YT; Wang J; Lu W; Cao Y; Cai W
    Cell Death Dis; 2016 Dec; 7(12):e2521. PubMed ID: 27977009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct Engagement of TLR9 Ligand with T Helper Cells Leads to Cell Proliferation & Up-regulation of Cytokines.
    Sharma RK; Sehgal S; Sachdeva N; Kumar R; Gupta A
    Immunol Invest; 2019 Jan; 48(1):79-95. PubMed ID: 30239236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-132 inhibits lipopolysaccharide-induced inflammation in alveolar macrophages by the cholinergic anti-inflammatory pathway.
    Liu F; Li Y; Jiang R; Nie C; Zeng Z; Zhao N; Huang C; Shao Q; Ding C; Qing C; Xia L; Zeng E; Qian K
    Exp Lung Res; 2015 Jun; 41(5):261-9. PubMed ID: 26052826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Toll-like receptor 9 signaling on activation of nasal polyp-derived fibroblasts and its association with nasal polypogenesis.
    Park SK; Jin SY; Yeon SH; Lee SB; Xu J; Yoon YH; Rha KS; Kim YM
    Int Forum Allergy Rhinol; 2018 Sep; 8(9):1001-1012. PubMed ID: 29901280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clostridioides difficile Toxin A Remodels Membranes and Mediates DNA Entry Into Cells to Activate Toll-Like Receptor 9 Signaling.
    Chen X; Yang X; de Anda J; Huang J; Li D; Xu H; Shields KS; Džunková M; Hansen J; Patel IJ; Yee EU; Golenbock DT; Grant MA; Wong GCL; Kelly CP
    Gastroenterology; 2020 Dec; 159(6):2181-2192.e1. PubMed ID: 32841647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Campylobacter jejuni disrupts protective Toll-like receptor 9 signaling in colonic epithelial cells and increases the severity of dextran sulfate sodium-induced colitis in mice.
    O'Hara JR; Feener TD; Fischer CD; Buret AG
    Infect Immun; 2012 Apr; 80(4):1563-71. PubMed ID: 22311925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-26a involved in Toll-like receptor 9‑mediated lung cancer growth and migration.
    Jiang DS; Wang YW; Jiang J; Li SM; Liang SZ; Fang HY
    Int J Mol Med; 2014 Jul; 34(1):307-12. PubMed ID: 24788552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epithelial toll-like receptor 9 signaling in colorectal inflammation and cancer: clinico-pathogenic aspects.
    Fűri I; Sipos F; Germann TM; Kalmár A; Tulassay Z; Molnár B; Műzes G
    World J Gastroenterol; 2013 Jul; 19(26):4119-26. PubMed ID: 23864774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-7-regulated TLR9 signaling-enhanced growth and metastatic potential of human lung cancer cells by altering the phosphoinositide-3-kinase, regulatory subunit 3/Akt pathway.
    Xu L; Wen Z; Zhou Y; Liu Z; Li Q; Fei G; Luo J; Ren T
    Mol Biol Cell; 2013 Jan; 24(1):42-55. PubMed ID: 23135998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorothioate modification of the TLR9 ligand CpG ODN inhibits poly(I:C)-induced apoptosis of hepatocellular carcinoma by entry blockade.
    Zhang Y; Lin A; Sui Q; Zhang C; Tian Z; Zhang J
    Cancer Lett; 2014 Dec; 355(1):76-84. PubMed ID: 25224571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthetic Human TLR9-LRR11 Peptide Attenuates TLR9 Signaling by Binding to and thus Decreasing Internalization of CpG Oligodeoxynucleotides.
    Pan X; Li B; Kuang M; Liu X; Cen Y; Qin R; Ding G; Zheng J; Zhou H
    Int J Mol Sci; 2016 Feb; 17(2):242. PubMed ID: 26907260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicted overlapping microRNA regulators of acetylcholine packaging and degradation in neuroinflammation-related disorders.
    Nadorp B; Soreq H
    Front Mol Neurosci; 2014; 7():9. PubMed ID: 24574962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ras participates in CpG oligodeoxynucleotide signaling through association with toll-like receptor 9 and promotion of interleukin-1 receptor-associated kinase/tumor necrosis factor receptor-associated factor 6 complex formation in macrophages.
    Xu H; An H; Yu Y; Zhang M; Qi R; Cao X
    J Biol Chem; 2003 Sep; 278(38):36334-40. PubMed ID: 12867418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The TLR9 Antagonist iCpG-ODN at Different Dosages Inhibits Cerebral Ischemia/Reperfusion Injury in Mice.
    Zhou Y; Pan J; Peng Q; Dong Z; Deng L; Wang Y
    CNS Neurol Disord Drug Targets; 2017; 16(5):624-633. PubMed ID: 28176622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oligonucleotides designed to inhibit TLR9 block Herpes simplex virus type 1 infection at multiple steps.
    Sauter MM; Gauger JJ; Brandt CR
    Antiviral Res; 2014 Sep; 109():83-96. PubMed ID: 24995383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-132 suppresses autoimmune encephalomyelitis by inducing cholinergic anti-inflammation: a new Ahr-based exploration.
    Hanieh H; Alzahrani A
    Eur J Immunol; 2013 Oct; 43(10):2771-82. PubMed ID: 23780851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Personalized genetics of the cholinergic blockade of neuroinflammation.
    Simchovitz A; Heneka MT; Soreq H
    J Neurochem; 2017 Aug; 142 Suppl 2(Suppl Suppl 2):178-187. PubMed ID: 28326544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.
    Abu-Rish EY; Amrani Y; Browning MJ
    Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recognition of CpG oligodeoxynucleotides by human Toll-like receptor 9 and subsequent cytokine induction.
    Suwarti S; Yamazaki T; Svetlana C; Hanagata N
    Biochem Biophys Res Commun; 2013 Jan; 430(4):1234-9. PubMed ID: 23266611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.